PatientRightsAdvocate.org sued the American Medical Association, arguing the AMA does not have valid copyright over CPT codes that providers must use for billing. The lawsuit follows a prior public letter from Senator Bill Cassidy that accused the AMA of charging fees tied to a government-backed monopoly. While not a drug-approval event, the case targets the infrastructure governing reimbursement, which can materially affect revenue cycles for healthcare providers and indirectly influence access to tests and therapies. For biotech, reimbursement policy is a key determinant of adoption speed for new diagnostics and treatments.